Thioridazine Hydrochloride Suppliers & Bulk Manufacturers
Available Forms: Oral tablets
Available Strengths: 10 mg, 25 mg, 50 mg, 100 mg, 200 mg
Reference Brands: Mellaril(US)
Category:
Antipsychotropic Drugs
Thioridazine Hydrochloride is an antipsychotic once marketed as Mellaril, used to treat schizophrenia. Available in 10 mg to 200 mg tablets, its use is now restricted due to cardiac risks. Still relevant for niche markets, it's a specialized product for B2B pharma suppliers focusing on psychiatric treatments.
Thioridazine Hydrochloride is available in Oral tablets
and strengths such as 10 mg, 25 mg, 50 mg, 100 mg, 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Thioridazine Hydrochloride is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Thioridazine Hydrochloride can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Thioridazine Hydrochloride is a typical antipsychotic medication used for the treatment of schizophrenia and other psychotic disorders. It belongs to the phenothiazine class and works by altering the actions of chemicals in the brain. Available in oral tablet form with strengths including 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg, Thioridazine is known under the brand Mellaril in the US, though its use has been limited due to cardiac risks. While largely discontinued in the US and many EU countries, it may still be found in niche markets. Ideal for pharma B2B platforms serving specialized psychiatric care.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing